Evidence map›Paper›PMID 31606788›Full record

ArticleAnnals of nuclear medicine2019

Manual on the proper use of yttrium-90-labeled anti-P-cadherin antibody injection for radionuclide therapy in clinical trials.

Makoto Hosono, Hideharu Ikebuchi, Seigo Kinuya, Sachiko Yanagida, Yoshihide Nakamura, Takahiro Yamada, Kenta Sakaguchi, Hiroyasu Sugano, Kiyotaka Kojima, Jun Hatazawa

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of nuclear medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Dose-response : a publication of International Hormesis Society
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Makoto HosonoDepartment of Radiology, Faculty of Medicine, Kindai University, 377-2 Ohno-Higashi, Osaka-Sayama, Osaka, 589-8511, Japan. hosono@med.kindai.ac.jp.ORCID http://orcid.org/0000-0001-8040-3245
Hideharu IkebuchiJapanese Society of Nuclear Medicine, Tokyo, Japan.
Seigo KinuyaJapanese Society of Nuclear Medicine, Tokyo, Japan.
Sachiko YanagidaJapan Radioisotope Association, Tokyo, Japan.
Yoshihide NakamuraJapan Radioisotope Association, Tokyo, Japan.
Takahiro YamadaAtomic Energy Research Institute, Kindai University, Higashi-Osaka, Japan.
Kenta SakaguchiDepartment of Radiology, Faculty of Medicine, Kindai University, 377-2 Ohno-Higashi, Osaka-Sayama, Osaka, 589-8511, Japan.
Hiroyasu SuganoFUJIFILM Toyama Chemical Co., Ltd., Tokyo, Japan.
Kiyotaka KojimaFUJIFILM Toyama Chemical Co., Ltd., Tokyo, Japan.
Jun HatazawaJapanese Society of Nuclear Medicine, Tokyo, Japan.
Japanese Society of Medical Oncology · JPKindai University · JPFujifilm (Japan) · JPJapan Radioisotope Association · JP

Funding

Ministry of Health, Labour and Welfare H28-Iryo-Ippan-014
6 · The paper itself

Abstract

We present the guideline for use of yttrium-90-labeled anti-P-cadherin antibody injection for radionuclide therapy in clinical trials on the basis of radiation safety issues in Japan. This guideline was prepared by a study supported by the Ministry of Health, Labour, and Welfare, and approved by the Japanese Society of Nuclear Medicine. Treatment using yttrium-90-labeled anti-P-cadherin antibody injection in Japan should be carried out according to this guideline. Although this guideline is applied in Japan, the issues for radiation protection shown here are considered internationally useful as well. Only the original Japanese version is the formal document.

Indexed as

Clinical Trials as TopicPractice Guidelines as TopicAntibodiesCadherinsHumansInjectionsIsotope LabelingPatient DischargeRadiation ProtectionSafetyYttrium RadioisotopesAntibodiesCadherinsYttrium-90Yttrium RadioisotopesRadiation protectionRadionuclide therapyYttrium-90-labeled anti-P-cadherin antibody

Identifiers

PMID31606788
PMCPMC6823325
OpenAlexW2980161659

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.